China shuts down test tube testing in Chengdu, U.S.: U.S. test tube market faces major impact

According to reports, China’s closure of the Chengdu test tube institution in the United States was completed in November 2021. These institutions are IVF service support agencies provided by the U.S. government in China and mainly provide U.S. IVF services. The closure of these institutions means that U.S. test tube services will not be supported in China, which has had a major impact on the development of the U.S. test tube industry.

The U.S. test tube market is facing unprecedented challenges. With the rise of China's economy and the improvement of U.S. test tube technology, the demand in the U.S. test tube market continues to increase. However, U.S. test tube institutions are facing tremendous competition and financial pressure. Under this circumstance, the U.S. government needs to find a new way to support the development of the U.S. test tube industry.

China's closure of its Chengdu test tube institution in the United States has had a major impact on the U.S. test tube market. Although U.S. test tube institutions are facing tremendous competitive and financial pressure, demand in the U.S. test tube market still exists. Under this circumstance, U.S. IVF institutions need to find a new way to meet market demand in order to maintain market competitiveness.